Dr. Loeb on Determining Beneficial Test Options for Prostate Cancer

Stacy Loeb, MD
Published Online: Tuesday, Jul 11, 2017



Stacy Loeb, MD, assistant professor of Urology and Population Health at New York University, discusses how to determine which test will be beneficial for the management of prostate cancer.

According to Loeb, since there are many tests available now, determining which test will be most beneficial to the patient is an unanswered question. Determining which test will provide helpful and actionable information while being the most cost effective is an area that will need further research.
 


Stacy Loeb, MD, assistant professor of Urology and Population Health at New York University, discusses how to determine which test will be beneficial for the management of prostate cancer.

According to Loeb, since there are many tests available now, determining which test will be most beneficial to the patient is an unanswered question. Determining which test will provide helpful and actionable information while being the most cost effective is an area that will need further research.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x